Predictive biomarkers for targeting insulin-like growth factor-I (IGF-I) receptor.
Carden
Craig P
CP
Drug Development Unit, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, United Kingdom.
Molife
L Rhoda
LR
de Bono
Johann S
JS
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017526:Receptor, IGF Type 1 / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D017526:Receptor, IGF Type 1